Systematic analysis of the relationship between antibiotic use and extended-spectrum beta-lactamase resistance in Enterobacteriaceae in a French hospital: a time series analysis

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 34, Issue 10, 2015, Pages 1957-1963

  Vibet, M A ^a   Roux, J ^b   Montassier, E ^b,c   Corvec, S ^b,c   Juvin, M E ^c   Ngohou, C ^c   Lepelletier, D ^b,c   Batard, E ^b,c  

^a INSERM   (France)

^b UNIVERSITÉ DE NANTES   (France)

^c NANTES UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; ANTISTAPHYLOCOCCAL AGENT; BETA LACTAMASE RESISTANT PENICILLIN; BETA LACTAMASE SENSITIVE PENICILLIN; CARBAPENEM DERIVATIVE; CEPHALOSPORIN DERIVATIVE; ENZYME INHIBITOR; EXTENDED SPECTRUM BETA LACTAMASE; IMIDAZOLE DERIVATIVE; LINCOSAMIDE; MACROLIDE; NITROFURANTOIN; PENICILLIN DERIVATIVE; PIPERACILLIN; POLYPEPTIDE ANTIBIOTIC AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT; QUINOLONE DERIVATIVE; STREPTOGRAMIN DERIVATIVE; SULFANILAMIDE; TETRACYCLINE DERIVATIVE; TICARCILLIN; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; CONTROLLED STUDY; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE INFECTION; ESCHERICHIA COLI; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ENTEROBACTERIACEAE; FRANCE; HOSPITAL INFECTION; HUMAN; INFECTION; KLEBSIELLA PNEUMONIAE; NONHUMAN; PRIORITY JOURNAL; TIME SERIES ANALYSIS; BACTERIAL INFECTIONS; CROSS INFECTION; DRUG EFFECTS; ENTEROBACTERIACEAE; MICROBIAL SENSITIVITY TEST; TIME FACTOR;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; BETA-LACTAM RESISTANCE; CROSS INFECTION; ENTEROBACTERIACEAE; FRANCE; HUMANS; MICROBIAL SENSITIVITY TESTS; TIME FACTORS;

EID: 84941426073     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-015-2437-3     Document Type: Article

References (36)

1. Zilberberg MD, Shorr AF (2013) Secular trends in gram-negative resistance among urinary tract infection hospitalizations in the United States, 2000–2009. Infect Control Hosp Epidemiol 34:940–946
2. Colodner R, Rock W, Chazan B et al (2004) Risk factors for the development of extended-spectrum beta-lactamase-producing bacteria in nonhospitalized patients. Eur J Clin Microbiol Infect Dis 23:163–167
3. Kaier K, Frank U, Hagist C et al (2009) The impact of antimicrobial drug consumption and alcohol-based hand rub use on the emergence and spread of extended-spectrum beta-lactamase-producing strains: a time-series analysis. J Antimicrob Chemother 63:609–614
4. Kanafani ZA, Mehio-Sibai A, Araj GF et al (2005) Epidemiology and risk factors for extended-spectrum beta-lactamase-producing organisms: a case control study at a tertiary care center in Lebanon. Am J Infect Control 33:326–332
5. Rodríguez-Baño J, Alcalá JC, Cisneros JM et al (2008) Community infections caused by extended-spectrum beta-lactamase-producing Escherichia coli. Arch Intern Med 168:1897–1902
6. Aldeyab MA, Harbarth S, Vernaz N et al (2012) The impact of antibiotic use on the incidence and resistance pattern of extended-spectrum beta-lactamase-producing bacteria in primary and secondary healthcare settings. Br J Clin Pharmacol 74:171–179
7. Vernaz N, Huttner B, Muscionico D et al (2011) Modelling the impact of antibiotic use on antibiotic-resistant Escherichia coli using population-based data from a large hospital and its surrounding community. J Antimicrob Chemother 66:928–935
8. Li D, Chen Y, Zhang W et al (2013) Risk factors for hospital-acquired bloodstream infections caused by extended-spectrum beta-lactamase Klebsiella pneumoniae among cancer patients. Ir J Med Sci 183:463–469
9. Gedik H (2012) Does antimicrobial use increase the rate of antimicrobial resistance? A one year experience. Indian J Med Microbiol 30:198–202
10. Gbaguidi-Haore H, Dumartin C, L’Hériteau F et al (2013) Antibiotics involved in the occurrence of antibiotic-resistant bacteria: a nationwide multilevel study suggests differences within antibiotic classes. J Antimicrob Chemother 68:461–470
11. Hsu LY, Tan TY, Tam VH et al (2010) Surveillance and correlation of antibiotic prescription and resistance of Gram-negative bacteria in Singaporean hospitals. Antimicrob Agents Chemother 54:1173–1178
12. Freeman JT, McBride SJ, Nisbet MS et al (2012) Bloodstream infection with extended-spectrum beta-lactamase-producing Enterobacteriaceae at a tertiary care hospital in New Zealand: risk factors and outcomes. Int J Infect Dis 16:e371–e374
13. Somily AM, Alsubaie SS, BinSaeed AA et al (2014) Extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in the neonatal intensive care unit: does vancomycin play a role? Am J Infect Control 42:277–282
14. Han JH, Nachamkin I, Zaoutis TE et al (2012) Risk factors for gastrointestinal tract colonization with extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli and Klebsiella species in hospitalized patients. Infect Control Hosp Epidemiol 33:1242–1245
15. Boetius Hertz F, Løbner-Olesen A, Frimodt-Møller N (2014) Antibiotic selection of Escherichia coli sequence type 131 in a mouse intestinal colonization model. Antimicrob Agents Chemother 58:6139–6144
16. Comité de l’Antibiogramme de la Société Française de Microbiologie (2014) Recommandations 2014. Available online at: http://www.sfm-microbiologie.org/UserFiles/files/casfm/CASFM_EUCAST_V1_0_2014.pdf. Last accessed 21 Jun 2014
17. Judge GG, Griffiths WE, Hill RC et al (1985) The theory and practice of econometrics. John Wiley & Sons, New York, 1056 pp
18. Hubert B, Watier L, Garnerin P et al (1992) Meningococcal disease and influenza-like syndrome: a new approach to an old question. J Infect Dis 166:542–545
19. Opatowski L, Varon E, Dupont C et al (2013) Assessing pneumococcal meningitis association with viral respiratory infections and antibiotics: insights from statistical and mathematical models. Proc Biol Sci 280:20130519
20. Geser N, Stephan R, Hächler H (2012) Occurrence and characteristics of extended-spectrum beta-lactamase (ESBL) producing Enterobacteriaceae in food producing animals, minced meat and raw milk. BMC Vet Res 8:21
21. Reist M, Geser N, Hächler H et al (2013) ESBL-producing Enterobacteriaceae: occurrence, risk factors for fecal carriage and strain traits in the Swiss slaughter cattle population younger than 2 years sampled at abattoir level. PLoS One 8:e71725
22. Geser N, Stephan R, Korczak BM et al (2012) Molecular identification of extended-spectrum-beta-lactamase genes from Enterobacteriaceae isolated from healthy human carriers in Switzerland. Antimicrob Agents Chemother 56:1609–1612
23. Batard E, Ollivier F, Boutoille D et al (2013) Relationship between hospital antibiotic use and quinolone resistance in Escherichia coli. Int J Infect Dis 17:e254–e258
24. Sun L, Klein EY, Laxminarayan R (2012) Seasonality and temporal correlation between community antibiotic use and resistance in the United States. Clin Infect Dis 55:687–694
25. Adams SJ, Cunliffe WJ, Cooke EM (1985) Long-term antibiotic therapy for acne vulgaris: effects on the bowel flora of patients and their relatives. J Invest Dermatol 85:35–37
26. Perez F, Pultz MJ, Endimiani A et al (2011) Effect of antibiotic treatment on establishment and elimination of intestinal colonization by KPC-producing Klebsiella pneumoniae in mice. Antimicrob Agents Chemother 55:2585–2589
27. Sherley M, Gordon DM, Collignon PJ (2004) Evolution of multi-resistance plasmids in Australian clinical isolates of Escherichia coli. Microbiology 150:1539–1546
28. Hoyen CK, Pultz NJ, Paterson DL et al (2003) Effect of parenteral antibiotic administration on establishment of intestinal colonization in mice by Klebsiella pneumoniae strains producing extended-spectrum beta-lactamases. Antimicrob Agents Chemother 47:3610–3612
29. Lautenbach E, LaRosa LA, Marr AM et al (2003) Changes in the prevalence of vancomycin-resistant enterococci in response to antimicrobial formulary interventions: impact of progressive restrictions on use of vancomycin and third-generation cephalosporins. Clin Infect Dis 36:440–446
30. Gupta K, Hooton TM, Naber KG et al (2011) International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis 52:e103–e120
31. Leroy J, Patry I, Faure C et al (2011) Regional audit on fluoroquinolones usage in the hospital and the community: are these antibiotics over-used? Pathol Biol (Paris) 59:e103–e107
32. Tängdén T, Eriksson BM, Melhus A et al (2011) Radical reduction of cephalosporin use at a tertiary hospital after educational antibiotic intervention during an outbreak of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae. J Antimicrob Chemother 66:1161–1167
33. Petrikkos G, Markogiannakis A, Papaparaskevas J et al (2007) Differences in the changes in resistance patterns to third- and fourth-generation cephalosporins and piperacillin/tazobactam among Klebsiella pneumoniae and Escherichia coli clinical isolates following a restriction policy in a Greek tertiary care hospital. Int J Antimicrob Agents 29:34–38
34. Lee J, Pai H, Kim YK et al (2007) Control of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a children’s hospital by changing antimicrobial agent usage policy. J Antimicrob Chemother 60:629–637
35. Livermore DM, Hope R, Reynolds R et al (2013) Declining cephalosporin and fluoroquinolone non-susceptibility among bloodstream Enterobacteriaceae from the UK: links to prescribing change? J Antimicrob Chemother 68:2667–2674
36. Schechner V, Temkin E, Harbarth S et al (2013) Epidemiological interpretation of studies examining the effect of antibiotic usage on resistance. Clin Microbiol Rev 26:289–307